Mission Biocapital — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
Telo Therapeutics, Inc.telotherapeutics.cominJun 2022SEC filingmedium confidence
Telo Therapeutics is a biotechnology company developing orally bioavailable next-generation small-molecule inhibitors of nuclear transport as cancer treatments.
BiotechHealthtechMedical DevicesSan Francisco, US
Rob Bell(Founder)inRobert Bell(Executive Officer, Director)inJoseph Costello(Director)Michael D. Taylor(Director)in
BoardRobert G. Blazej(Director)in
Board seatRobert BlazejMichael Taylor· per SEC Form D · $10.2M raise · filed Jun 2022
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.